Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Miriam Sciaccaluga, Alfredo Megaro, G. Bellomo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5991-5991
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Aducanumab—Hope or Disappointment for Alzheimer’s Disease
Karolina Wojtunik‐Kulesza, Monika Rudkowska, Anna Orzeł-Sajdłowska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4367-4367
Open Access | Times Cited: 44
Myelin in Alzheimer’s disease: culprit or bystander?
Michel Maître, Hélène Jeltsch‐David, Nwife Getrude Okechukwu, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 32
Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond
Elise K. Webber, Marc Fivaz, Grace E. Stutzmann, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3701-3717
Open Access | Times Cited: 23
Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 2
Open Access | Times Cited: 22
Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways
Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102211-102211
Closed Access | Times Cited: 13
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 13
Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration
Maja Jazvinšćak Jembrek, Nada Oršolić, Lucija Mandić, et al.
Antioxidants (2021) Vol. 10, Iss. 10, pp. 1628-1628
Open Access | Times Cited: 49
Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures
Macarena S. Aloi, Katherine E. Prater, Raymond Sanchez, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 20
TMS-EEG perturbation biomarkers for Alzheimer’s disease patients classification
Alexandra-Maria Tăuƫan, Elias Paolo Casula, Maria Concetta Pellicciari, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions
Thomas Gabriel Schreiner, Oliver Daniel Schreiner, Maricel Adam, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1411-1411
Open Access | Times Cited: 18
The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy
Fabio Perversi, Cinzia Costa, Angelo Labate, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 18
Imidacloprid and thiamethoxam affect synaptic transmission in zebrafish
Jinge Zhang, Dong-Dong Ma, Qian Xiong, et al.
Ecotoxicology and Environmental Safety (2021) Vol. 227, pp. 112917-112917
Open Access | Times Cited: 34
The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents
Geoffrey Canet, Charleine Zussy, Célia Hernandez, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108398-108398
Open Access | Times Cited: 13
Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms
Kashif Abbas, Mohd Rais Mustafa, Mudassir Alam, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access
The role of parvalbumin interneuron dysfunction across neurodegenerative dementias
Carmelo Smeralda, Siddhartha Pandit, Sonia Turrini, et al.
Ageing Research Reviews (2024), pp. 102509-102509
Closed Access | Times Cited: 4
Potential therapeutic targets for Alzheimer’s disease: Fibroblast growth factors and their regulation of ferroptosis, pyroptosis and autophagy
Yiwei Li, Chenbo Yang, Xiaonan Liu, et al.
Neuroscience (2025)
Closed Access
Subregional Functional Connectivity of the Precuneus as a Preclinical Biomarker in Alzheimer’s Disease
Claudia Aponte, Antonio Jiménez-Marín, Malen Razkin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: a new perspective
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Acta Neurologica Belgica (2023) Vol. 124, Iss. 2, pp. 377-388
Open Access | Times Cited: 10
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
Francesca Bosco, Lorenza Guarnieri, Vincenzo Rania, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12639-12639
Open Access | Times Cited: 9
c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases
Alejandra Álvarez, DanielaA Gutiérrez, América Chandía-Cristi, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 2, pp. 237-237
Open Access | Times Cited: 15
Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism
Yiying Li, Kai-Yue Yu, Yujia Cui, et al.
Neurobiology of Aging (2023) Vol. 124, pp. 71-84
Closed Access | Times Cited: 7
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits
Laura Bellingacci, Jacopo Canonichesi, Miriam Sciaccaluga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1377-1377
Open Access | Times Cited: 2
Integration of Microfluidic Devices with Microelectrode Arrays to Functionally Assay Amyloid-β-Induced Synaptotoxicity
Camille Lefebvre, Anaïs-Camille Vreulx, Corentin Dumortier, et al.
ACS Biomaterials Science & Engineering (2024) Vol. 10, Iss. 3, pp. 1856-1868
Closed Access | Times Cited: 2
Qifu-yin activates the Keap1/Nrf2/ARE signaling and ameliorates synaptic injury and oxidative stress in APP/PS1 mice
Sulei Wang, Jing Huang, Yan‐Ting Chen, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118497-118497
Closed Access | Times Cited: 2
Elevated concentrations of amyloid‐β oligomers and their proapoptotic effects on age‐related cataract
Peimin Lin, Jie Xu, Fan Yang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 17
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top